Blueprint Medicines is seeking an innovative, collaborative and enthusiastic scientist to work on a variety of high-dimensional bioinformatics projects centered on target identification and drug discovery. The individual will integrate internal and external datasets, including next generation sequence data and tumor cell response data. The successful candidate will develop tools and analysis strategies to filter and distill complex datasets to generate focused hypotheses and drive target identification/validation. A critical component of the job will be close collaboration with internal drug discovery teams and external investigators.
Applicants should have PhD in bioinformatics, biology, genetics or related A minimum of three years of relevant work experience in bioinformatics or computational biology in an academic or professional setting is recommended.
Candidates should have a solid scientific background and proven high levels of performance, as evidenced by a strong publication
Successful applicants must have in-depth understanding of current best practices in high- throughput molecular data analysis and broad experience with one or more platforms, such as next-generation sequencing, multiplexed qPCR, flow cytometry and
Candidates should also have a strong background in using a high-level programming language, such as R, MATLAB, Python or Perl for complex data analysis.
Excellent communication, data presentation and visualization skills are also
Creatively collaborate to develop a platform for genomics-based target
Apply and develop tools for integrative analysis and visualization of multi-dimensional datasets (biochemical, cellular and genomic data) using appropriate statistical
Regular publication of both scientific and methodological results is strongly
Effectively present complex results in a concise manner accessible to a diverse
There is potential for a management role for candidates more advanced in their careers.
Blueprint Medicines’ mission is to dramatically improve the lives of patients with genomically defined diseases. Our singular focus is to use our deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases to craft highly selective medicines aimed at eradicating these diseases. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking. We believe we are at our best as a company when our employees are thriving and foster a culture that provides opportunities to grow and develop professionally, while also having fun.